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Abstract 
This study compared the bone forming capacity of the same formulation of silicate-substituted bone graft 
substitute materials with different microporosity in an instrumented posterolateral spinal fusion ovine 
model.  Materials with a strut porosity of (i) 22.5% (SiCaP) or (ii) 36.0% (SiCaP(+)) were packed along 
either side of the spine.  Bone apposition rates, % new bone formation, % bone-scaffold contact and % 
graft resorption were quantified at 8, 12 and 24 weeks post surgery.  Computed Tomography (CT) was 
used to grade the formation of fusion bridges between vertebrae.  Results showed no significant 
difference in bone apposition rates, % new bone formation and % bone-implant contact when the two 
materials were compared.  However, at 8 weeks, a significantly higher CT score was obtained in the 
SiCaP(+) group (0.83 ± 0.17) when compared with the SiCaP group (0.17 ± 0.17; p = 0.027). 
Significantly less scaffold remained in the SiCaP(+) group at 12 weeks (p = 0.018).  Both SiCaP and 
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SiCaP(+) formulations augmented bone formation.  Increasing the strut porosity did not significantly 
increase bone formation however, at 8 weeks it promoted the formation of more highly mineralised bone 
resulting in a significantly higher CT score, suggesting the bone tissue formed was more mature. 
 
Keywords: Bone regeneration; posterolateral spinal fusion; osteoconduction; strut porosity; calcium 
phosphate; sheep model; bone substitute materials. 
 
Introduction 
The most common application of bone graft is in posterolateral spinal fusion surgery, where the graft is 
used to create a bony bridge between the vertebrae that connects and stabilises the affected segments.  
The procedure is believed to be one of the most challenging indications for bone graft due to the large 
distance that needs to be bridged, limited contact surface available and the unfavourable biomechanical 
environment due to the lack of compression forces [1].   Presently autograft harvested from the iliac crest 
is considered the 'gold standard' for regenerating bone due to its biological performance in terms of 
osteoinductivity [2 - 4] and osteoconductivity [4 – 6]. However, the amount of iliac crest bone available is 
limited and its harvesting is associated with increased operative and recovery times and significant donor 
site morbidity [7, 8].     
 
Calcium phosphate based ceramic bone graft substitute materials represent an alternative to autologous 
bone and have been successfully used in the repair of bony defects caused by trauma, malignancy and 
infection [7, 9 – 11].  Several studies have shown that their bioactivity can be significantly augmented 
through chemical substitution of phosphate ions with silicate ions [12 – 14].  In a recent study by Wheeler 
et al. [15], the use of silicate-substituted calcium phosphate (SiCaP) graft in an instrumented 
posterolateral fusion model was reported to be biomechanically, radiographically and histologically 
equivalent to autograft, generating a solid, bony inter-transverse process fusion in an ovine model.  In 
addition, two clinical studies that investigated the effect SiCaP in patients following spinal fusion 
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surgery, reported 90% [8] and 100% [16] levels of bony fusion and concluded it to be an effective bone 
graft substitute that eliminated the need for autogenous iliac crest bone graft.   Studies have since 
questioned whether the efficacy of SiCaP is due to the presence of silicon or the resulting microstructure 
[17, 18].  A number of studies have reported the significant effect of silicate ions on augmenting bone 
formation [12 – 14] whilst other reports have shown that increasing the strut (micro)porosity of porous 
SiCaP significantly augments the repair, regeneration and bone-implant contact in both ectopic and 
orthotopic sites [19 – 22].   In this study, we asked the question whether a SiCaP scaffold with increased 
strut porosity would further enhance the regenerative bony capacity and increase bone bridging in an 
ovine posterolateral spinal fusion model.  Our hypothesis was that silicate-substituted scaffolds with 
increased strut porosity would significantly increase bone formation and enhance fusion.   
 
Materials and Methods 
The two SiCaP scaffolds investigated (1) SiCaP and (2) SiCaP(+) (supplied by ApaTech Ltd, Herts, UK 
in the form of irregularly shaped 1 – 2 mm sized granules), had the same total macroporosity of 80 – 
82.5% with an average macropore diameter of 300 µm, and differed only in the level of strut porosity 
(micropores within the struts were < 50 μm in diameter and had a typical diameter of 1 to 10 μm).  
Scaffolds in experimental Group 1 (SiCaP) were manufactured with a strut porosity of 22.5 ± 2.5% (mean 
with standard deviation of mean) and in Group 2 (SiCaP(+)) materials had a strut porosity of 36.0 ± 2.5%.  
Both materials were composed of phase pure hydroxyapatite substituted with 2.6 wt% silicate (equivalent 
to 0.8 wt% Si).  
 
Porous ceramic foams with varied strut porosity were manufactured via a foaming route [23] and the 
phase purity confirmed using X-ray diffraction (XRD) as previously described [23].  The calcium, 
phosphorus, and silicon contents were determined by X-ray fluorescence (XRF) [23] and total porosity 
was confirmed according to a water immersion densitometry method [24]. The strut-porosity was 
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confirmed by mercury intrusion porosimetry in combination with helium pyconometry as detailed in our 
previous study [19].   
 
Thirty-six bilateral, instrumented, posterolateral spinal fusion procedures were performed on 36 skeletally 
mature female commercially cross-bred sheep, 2 – 5 years of age and weighing between 65 – 85 kg. All 
procedures were carried out following Ethics approval granted by the Royal Veterinary College and in 
compliance with U.K Home Office regulations as stated in the Animal Scientific Procedures Act (1986). 
Animals were euthanised at 8, 12 or 24 weeks post surgery.  A total of six animals implanted with each 
bone graft type were investigated in each group at each of the three time points. 
 
Surgery 
Animals were placed in dorsal recumbence and longitudinal incisions measuring approximately 6 - 8 cm 
were made over the spinous processes from L3 to L5. Through this skin incision, the subcutaneous 
muscle firstly to the right lateral side of the spinal column was divided by blunt dissection to expose the 
transverse processes.   The transverse processes of L4 and L5 and the adjacent spine, laminae, 
posterolateral aspect of the pars and facet joints were cleared of soft tissue and the facet joint excised.  
Decortication of the dorsal aspect of each transverse process and lateral spine was carried out using a burr 
and pedicle screws inserted.  An interconnected rod was applied and 8 cc of bone graft material packed 
between the two transverse processes.  The graft which bridged the two transverse processes, was placed 
onto the decorticated surfaces, around the dorsal facets, around the pedicle screws and inferior to the 
metallic rod implants (Nuvasive, San Diego, USA). The inter-granular distance was not measured and 
assumed to be the same in all cases as the packing technique was similar. The wound was then carefully 
closed in layers. Prior to closure of the skin, the procedure was repeated on the contralateral side.  The 
graft material for one animal inserted onto the right and left hand sides of the spine was the same and 
surgeons were not blinded to the graft-type implanted.  Following surgery, animals were administered 
with routine prophylactic antibiotics and analgesia and were allowed to mobilise as tolerated. Implants 
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remained in vivo for 8, 12 or 24 weeks.  These time-points were chosen as they are considered clinically 
relevant time-points.   Fusion associated with bone formation in spinal fusion surgery has been shown to 
occur at 24 weeks and the 8 and 12 week time-points investigated in this study allowed us to assess the 
early and mid-bony response.  All analyses were carried out blind to implant type. 
 
Bone Apposition Rates 
When administered in vivo, fluorochromes that absorb to bone mineral can be used as markers for 
quantifying the active mineralising surfaces of bone.  When two or more markers with different emission 
spectra are administered at known time points, bone apposition rates (μm/day) can be quantified by 
measuring the distance between markers when viewed under UV light.  In this study, oxytetracycline (30 
mg/kg) and Alizarin Red (30 mg/kg) were intravenously administered at 5 and 7 weeks in the 8-week 
group, at 9 and 11 weeks in the 12-week study group and at 20 and 22 weeks in the 24-week group.   
 
Following euthanasia, the spinal column between L3 – L6 was retrieved en bloc with surrounding muscle. 
Samples were fixed and preserved using 4% paraformaldehyde for 7 days and were then processed for 
undecalcified histology. After dehydration in a graded alcohol series and defatting using chloroform 
solution, the samples were embedded in polyhydroxy-aromatic acrylic resin (LR WhiteTM from The 
London Resin Company, Reading, United Kingdom). The specimens were cut transversely through the 
affected lumbar region in the dorsal/ventral plane and thin sections (~ 60 µm) were prepared using an 
EXAKT grinding system (EXAKT Corp, Norderstedt, Germany). Longitudinal thin sections were also 
prepared through the cranial/caudal plane in each of the animals.  Measurements were taken from 7 
regions of interest within the graft material using fluorescence microscopy.  Image analysis techniques 
(Axiovision 4.5; Carl Zeiss, Jena, Germany) were used to quantify the measurable differences between 
the two bone markers. 
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Histological Evaluation 
Following measurements for bone apposition rates sections were subsequently stained with Toluidine 
Blue and Paragon (stains soft tissue and bone, respectively).  The sections were examined histologically 
using light microscopy (Figure 1). ‘Bone formation within the bone graft substitute material was 
measured from a transverse section taken mid-way between the two transverse processes. Five 
images spanning the thin section were captured using a 5× objective lens and analyzed with use of 
image analysis software (AxioVision 4.5; Carl Zeiss, Jena, Germany). The line intersection method 
[14, 19, 20] was used to quantify the percentage of bone within the graft material, and of implant 
material in the image.  A 10 × 12-mm grid of lines was placed over the image. The type of material 
present at each of the 225 intersection points of the grid lines was determined. Bone in direct 
contact with the implant surface (bone-implant contact) was determined at the points where the 
lines intersected with the SiCaP or SiCaP(+) biomaterial.  The percentage of tissue, material and 
bone-implant contact was then calculated as a mean from a set of five images of each implant and 
statistical comparisons were performed.‘Bone was not quantified in pores < 50 µm.  In order to 
investigate whether bone formation had resulted in fusion of the spine, sections orientated longitudinally 
(cranial-caudal plane) between the vertebrae and the spinal rod were also made.  As reported above, the 
spinal fusion mass was sectioned transversely (dorsal-ventral plane) and in order to obtain longitudinal 
histological images, three sections (A, B and C) equivalent to a single longitudinal section were 
constructed. 
 
Computed Tomography 
Computed tomography (CT) was carried out on the 12 animals in the 24-week group only, at 8, 16 and 24 
weeks post surgery.  Multi-planar 3-Dimensional image reconstructions (in the coronal and sagittal plane) 
of axial CT images were carried out using QMA (Medical Metrics, Inc, Houston, Texas USA).  The CT 
imaging protocol consisted of 0.6 mm thick and 0.3 mm overlapping axial slices with levels adjusted to 
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optimise trabecular bone detail.  An independent veterinary radiologist performed blinded CT 
assessments as follows: 
 
(i) Bridging Bone (Fusion) 
Evidence of bridging bone in CT images across the implanted posterior elements was semi-quantitatively 
graded in accordance with the following scoring system: 
 
0. None – no evidence of callus formation associated with dorsal articular facets (articular 
surfaces well defined). 
1. Minimal Callus Formation – Some callus formation is present however the callus is poorly 
defined (amorphous) and not consolidated between the facets (articular surfaces still well 
defined). 
2. Partial Callus Formation – Callus formation is present and the callus appears better defined 
and is beginning to consolidate across the facets (articular surfaces lack some definition). 
3. Fusion – Callus formation is present and it is well defined, consolidated and bridging between 
the facets (articular surfaces poorly defined). 
 
(ii) Adjacent Level Degeneration 
Evidence of adjacent level degeneration graded in accordance with the following definitions: 
 
0 Absent – No evidence of disc mineralisation, osteophyte formation, endplate sclerosis and/or 
disc height loss at the level(s) adjacent to the treated level suggestive of degeneration. 
1 Present – Presence of disc mineralisation, osteophyte formation, endplate sclerosis and/or disc 
height loss at the level(s) adjacent to the treated level suggestive of degeneration. 
 
(iii) Implant Loosening or Infection 
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Evidence of loosening of the implant or gross signs of infection at the treated level: 
 
0. Absent – No Evidence of implant loosening or infection at the treated level. 
1. Present – Presence of implant loosening or infection at the treated level 
 
 
Statistics 
The Mann-Whitney U test was used for statistical analysis between experimental groups where P values < 
0.05 were considered significant.  The Kruskal-Wallis test with post-hoc Mann-Whitney U tests were 
used to compare data at different time points and within one experimental group where P values < 0.05 
were considered significant (version 10.1; SPSS, Chicago, Illinois).  Mean values are presented with 
standard error of mean. 
 
RESULTS 
Bone Apposition Rates 
No significant difference in bone apposition rates within the bone graft were seen when the two 
experimental groups were compared at 8, 12 and 24 weeks.  Over a 24 week period, bone apposition rates 
decreased over time with lowest rates measured in both groups at the 24-week time-point (mean SiCaP, 
1.33 ± 0.23 μm/day, mean SiCaP(+), 1.76 ± 0.32 μm/day) (Figure 2).  In the SiCaP group, a significantly 
higher bone apposition rate was measured at 8 weeks (2.93 ± 0.33 μm/day) when compared with the 24 
week time-point (p = 0.010).  No other significant differences were found. 
 
New Bone Formation 
Similar amounts of new bone formation were measured within the SiCaP and SiCaP(+) scaffolds and 
results showed no significant differences when the 8, 12 and 24-week time points were compared.     
Histological analysis revealed that new bone formation increased over time in both groups.  In the SiCaP 
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group, significantly increased levels of bone formation was measured within the graft material at 12 
weeks (mean, 46.28% ± 0.68%) when compared with 8 week data (mean, 32.88% ± 0.79%) (p = 0.006).  
At 24 weeks significantly increased bone was measured (mean, 54.14% ± 3.96%) when compared with 
bone present 8 weeks post surgery (p = 0.004).  No significant difference was found when 12 and 24-
week data was compared.  In the SiCaP(+) group,  a significantly increased amount of bone was 
measured in the 24 week group (mean, 58.07% ± 3.31%) when compared with both the 8 week (mean, 
32.75% ± 2.39%) and 12 week groups (mean, 40.34% ± 3.56%) (p = 0.003 and p = 0.016 respectively).  
No significant difference was measured when the 8 and 12-week groups were compared. 
 
Bone-Graft Substitute Contact 
Results showed similar amounts of % bone-implant contact in the two experimental groups.  No 
significant differences were found when the two groups were compared at any of the three time-points 
investigated in this study.  Longitudinal analysis showed a trend where bone-implant contact increased 
over time in both groups.  In SiCaP samples, significantly increased bone-implant contact was measured 
at 24 weeks (mean, 84.63% ± 1.56%) when compared with both the 8-week group (mean, 60.76% ± 
1.73%) and 12 week group (75.87% ± 1.67%) (p = 0.004 and p = 0.006 respectively).  A significant 
increase in contact was also measured in the 12 week group when compared with the 8 week group (p = 
0.006).   In the SiCaP(+) group, significantly increased bone-implant contact was measured in the 24 
week group (mean, 83.77% ± 1.09%) when compared with both the 8 week (59.25% ± 4.75%) and 12 
week group (mean, 71.68% ± 3.59%) (p = 0.003 and p = 0.025 respectively).  No significant difference 
was found when the 8 and 12-week groups were compared. 
 
Bone Graft Resorption 
Results showed that significantly less implant remained in the SiCaP(+) group at 12 weeks (mean, 
21.58% ± 2.35%) when compared with graft remaining in the SiCaP group (mean, 30.87% ± 1.49%) (p = 
0.018).  No significant differences were found when the two groups were compared at 8 and 24 weeks.   
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Analysis showed a trend in both groups where implant resorption increased over time.  In the SiCaP 
group, significantly less implant remained at 24 weeks (mean, 22.74% ± 1.04%) when compared with 
both the 12 (mean, 30.87% ± 1.49%) and 8 week groups (mean, 29.98% ± 0.67%) (p = 0.006 and p = 
0.004 respectively).  No significant difference was found when the 8 and 12 week data was compared.  In 
the SiCaP(+) group, significantly less graft material remained at 12 weeks (mean, 21.58% ± 2.35%) and 
24 weeks (mean, 21.38% ± 2.03%) when compared with the 8 week group (mean, 29.95% ± 0.98%) (p = 
0.022 and p = 0.004 respectively).  No significant difference was found when the 12 and 24 week data 
was compared. 
 
Light Microscopy  
Light microscopy confirmed the presence of bone formation throughout both SiCaP and SiCaP(+) 
graft materials and evaluation did not identify any significant differences in the pattern of bone 
formation associated with either group.  Transverse sections showed bony fusion masses on both 
sides of the spine in most cases.  There was some variation in the size of the fusion mass although 
this did not appear to correlate with the graft type used.  At 8 weeks, dense bone formation was 
generally observed in the graft closest to the vertebrae but by 24 weeks, bone formation was more 
uniformly spread throughout the fusion mass.  In some cases sporadic islands of bone formation 
were observed within the peripheral regions of the graft bed, suggestive of osteoinductive bone 
formation in these regions.  Both intramembranous and endochondral ossification was observed 
within the fusion masses of both the SiCaP and SiCaP(+) treated spines.  Even in the same fusion 
mass, both types of bone formation could often be seen.  The presence of endochondral ossification 
was unexpected, but was consistently observed throughout both specimen types. Initially bone 
appeared to preferentially form along the granule concave macropore surfaces with subsequent 
bone being deposited in a concentric manner (Figure 3). 
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In many cases and in both groups, bone was seen bridging between granules and binding the fusion 
mass together.  Extensive bone growth was seen throughout the strut- and macropore network in 
both graft materials over the 8, 12 and 24 week investigative period.  Although not quantified in 
this study, strut pores appeared largely filled with bone with no obvious differences when the SiCaP 
and SiCaP(+) samples were compared.  Where minimal bone formation had occurred particularly in 
the 8-week group, granule degradation was apparent.  These regions were often associated with 
macrophage-like cells containing graft particles and in addition the presence of multinucleate cells 
on the surface of the graft material could be identified in some regions (Figure 4). 
 
In specimens in both groups and as early as 8 weeks, qualitative examination of the longitudinally 
cut specimens showed the presence of a fusion bridge from one vertebral body to the adjacent 
vertebra (Figure 5).  In other specimens although new bone formation was evident, fusion had not 
yet completely bridged the vertebrae together.  This was also the case at 12 weeks however at 24 
weeks, all animals appeared to have fusion masses that had to some degree, bridged along the 
length of the spine.  
 
X-Ray Computer Tomography 
In both the SiCaP and SiCaP(+) groups, a trend over time was seen where callus formation became 
more radio-opaque and better defined as a result of consolidation and bony remodelling.  In most 
animals in both groups, the callus was more defined and consolidated at 24 weeks when compared 
with the 8 and 16 week time points (Figure 6). 
 
Semi-quantitative analysis of bone bridging showed that at 8 weeks post surgery and in both 
experimental groups, no bone bridging between the two dorsal articular facets was identified.  In the 
SiCaP group, only one animal presented radiological indicators for the presence of a poorly defined 
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callus.  All other animals in this group were considered to be completely un-fused (mean score, 
0.17 ± 0.17).  In the SiCaP(+) group at 8 weeks, a significantly higher semi-quantitative score was 
seen where callus formation was observed in 5 of the 6 animals and only one animal was un-fused 
(mean score, 0.83 ± 0.17) (p = 0.027) (Figure 7).  At 16 weeks, none of the vertebrae were 
considered fused and the mean bone bridging score was similar in both groups (SiCaP mean, 1.50 ± 
0.22; SiCaP(+) mean, 1.67 ± 0.21).   At 24 weeks post surgery, 2 of the 6 animals in the SiCaP 
group had well defined callus that was considered fused (mean score, 2.17 ± 0.31).  Results were 
similar in the SiCaP(+) group where the callus in 3 of the 6 animals was seen to have fused (mean 
score, 2.33 ± 0.33).  No significant differences in scores were identified between the two groups at 
16 and 24 weeks.  When results were compared over time, a significant increase in score was 
observed in the SiCaP group when the 8-week data was compared with both the 16 week (p = 
0.005) and 24 week data (p = 0.003).  No significant increase in score was measured when the 16 
and 24-week data were compared.  Similarly, in the SiCaP(+) group, a significant increase in score 
was measured when the 8 week data was compared with both the 16 week (p = 0.018) and 24 week 
data (p = 0.007).  No significant difference was found when 16 and 24-week data were compared. 
 
No signs of implant loosening, infection or implant migration into the intervertebral disc space were 
observed in any of the animals investigated.  In addition, no evidence of disc degeneration, gross 
bone resorption, gross resorption or chemical degradation of the graft was reported.  None of the 
animals investigated in this study developed osteophytes, endplate sclerosis, disc mineralisation or a 
loss in disc height in adjacent vertebrae.  
 
DISCUSSION 
Previous work has shown that increasing strut porosity in silicate-substituted calcium phosphate 
bone graft materials significantly increased their bone regenerative capacity in ectopic and 
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orthotopic models [19 – 22].  The aim of this study was to investigate whether bone regeneration 
within a SiCaP scaffold with an average strut porosity of 22.5% strut porosity could be further 
enhanced when the strut porosity was increased to 36.0% in an ovine posterolateral spinal fusion 
model at 8, 12 and 24 weeks post-operatively.  Following surgery, animals showed no signs of 
implant loosening, infection or implant migration as well as no evidence of disc degeneration or 
gross bone resorption.  None of the animals investigated developed osteophytes, endplate sclerosis, 
disc mineralisation or a loss in disc height in adjacent vertebrae and so normal healing and 
maturation of the fusion mass was compared in both groups.    
 
Increased strut porosity is thought to provide an increased surface area for the action of angiogenic 
and other proteins leading to the formation of blood vessels and promoting bone induction by 
osteoblasts at early time points [25, 26].  Studies have also shown that scaffolds with high strut 
porosity have increased levels of serum proteins, such as vascular endothelial factor, adsorbed onto 
the surface [27, 28]. As well as providing an increased surface area for the action of angiogenic and 
other proteins leading to the formation of blood vessels and promoting bone induction by 
osteoblasts [25, 26], a study by Campion et al. [21] reported that increased porosity encouraged 
earlier neovascularisation and increased bone growth in a femoral condyle critical-sized defect 
model. Chemical composition [7, 20], scaffold macroporosity and pore interconnectivity [29] are 
also known to influence bone formation within the graft, but all remained constant in this study; the 
only variation between treatment groups was the strut porosity. Although fusion and bone formation 
within the graft was seen to increase over time in both of the groups investigated, results from our 
study showed that similar amounts of bone had formed.   Our study showed a significantly higher 
CT grading score in the SiCaP(+) group at 8 weeks, indicating an earlier increase in the amount of 
mature and mineralised bone tissue formed.  This may have occurred as a result of the tissue having 
been there longer and/or being formed by a different and faster mechanism.  Results also showed a 
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significant reduction in the amount SiCaP(+) scaffold present at 12 weeks suggesting that an 
accelerated response to adaptive graft remodelling may have also occurred. Therefore, our results 
only partially supported our hypothesis as significantly increased volumes of new bone formation 
were not observed in the SiCaP(+) treated fusions of healthy animals at any of the study time points 
of 8, 12 and 24 weeks, nor were there any significant differences in the bone apposition rates 
measured between 5 – 7, 9 – 11 and 20 – 22 weeks.  However, the results of the CT analysis 
suggest that the bone in the SiCaP(+) treated fusions was significantly more densely mineralised at 
8 weeks, suggesting a greater maturity in the bone tissue within these grafts at this early time-point.  
These results suggest that the presence of greater levels of strut porosity either promoted early bone 
formation with a more ordered morphology or accelerated the rate of bone formation at the very 
early (< 5 weeks) time point.  In previous studies we have found strut porosity to be critical to the 
capacity of a synthetic graft to display osteoinductive behaviour [14, 19, 20].  In the current fusion 
model the grafts were placed in contact with well decorticated bone in relatively young and healthy 
animals which would have presented less of a challenge to bone formation than either an ectopic 
model or in the fusion of patients with diseased or degenerated bone stock.  Thus to fully 
understand the role of strut microporosity further work is required to investigate the early response 
of bone tissue formation, maturation and mineralisation in the presence of silicate-substituted 
scaffolds with increased strut porosity.   
 
In patients, a lack of fusion between vertebrae may eventually lead to mechanical failure of the 
internal fixation. In this study, CT results showed complete mineralised fusion in 2/6 animals in the 
SiCaP group and 3/6 animals in the SiCaP(+) group at 24 weeks post surgery.  Fusion is indicative 
of active bone formation, and histological results showed an increase in bone formation over time 
with an exponential decrease in the quantity of implant present, particularly in the SiCaP(+) group.  
In both SiCaP and SiCaP(+) specimens and at all time points, extensive bone formation had 
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occurred within both the strut- and macropores with remodelled mature bone seen bridging the 
granules within the graft together.   Both of these grafting options produced significant integration 
of bone within the graft mass with little evidence of fibrous tissue interposition, especially at 24 
weeks post surgery. Results showed the SiCaP(+) scaffold to remodel significantly faster than 
SiCaP, it is possible that this may further augment the rate of onset of adaptive remodelling. A 
post-hoc power analysis was performed and results showed that even with the lowest non-
significant value > 40 samples per group are required for a study power of 80% with a p < 
0.05.  This confirms that the results for bone integration obtained when the two experimental 
groups were compared, showed little difference.  Biomechanical assessments at the time points 
investigated would have provided additional information on the progression of healing and the 
development of functional fusion [15, 30].  However, the mechanical integrity of the regenerated 
fusion mass was not measured in this study. 
 
Conclusion 
Increasing the strut porosity did not significantly increase the amount of bone formed however, it 
did accelerate the rate of early mineralised bone tissue formation, resulting in a significant increase 
in the amount of mineralised tissue at 8 weeks in the SiCaP(+) group as measured using our semi-
quantitative score and based on the radiographic density of bone.  Further work is required to 
investigate the early response of bone tissue formation, maturation and mineralisation in the 
presence of silicate-substituted scaffolds of increased strut porosity.  Our work also raises the 
question of whether further increases in strut porosity is advantageous for improving 
osteointegration. Experiments to elucidate this are required however it should be recognized 
that structural integrity of the graft material may be compromised by high strut porosities. 
However, for spinal fusion where load is often taken by the instrumentation before bone has 
formed, bone graft substitute weakness may not be problematic. 
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Figure Legends 
Figure 1: A low power photomicrograph of a transverse section through the L4/5 of an animal in 
the SiCaP group at 24 weeks showing extensive bone formation and new bone in contact with the 
lamellae. 
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Figure 2: Bone apposition rates [A], percentage new bone formation [B], bone scaffold contact 
[C] and implant area remaining [D] within SiCaP and SiCaP(+) scaffolds over the 8, 12 and 
24-week time periods investigated. 
 
Figure 3:  High power photomicrographs showing [A] intramembranous ossification adjacent 
to a SiCaP surface at 8 weeks, [B] endochondral ossification in an 8 week SiCaP(+) sample, 
[C] bone formation onto the concave surfaces of a SiCaP scaffold at 12 weeks and [D] bone 
bridging between SiCaP(+) granules at 12 weeks post surgery. 
 
Figure 4: High power photomicrographs showing new bone formation on the surface of the 
scaffold at 8 weeks post-surgery with bone seen within adjacent struts in [A] the SiCaP group 
and [B] the SiCaP(+) group. Figure 4C shows bone formation within the SiCaP scaffold struts 
at 12 weeks post surgery and [D] extensive bone growth throughout the micropore structure 
in a SiCaP(+) scaffold at 24 weeks post surgery. 
 
Figure 5: A photograph of longitudinal sections A, B and C approximated together showing bone 
bridging in a SiCaP(+) specimen at 8 weeks post surgery. 
 
Figure 6: CT images of an animal in the SiCaP(+) group at 8, 16 and 24 weeks post-implantation 
showing fusion at 24 weeks. 
 
Figure 7: A graph showing the results obtained when bone bridging was graded from CT data 
obtained from animals in the SiCaP and SiCaP(+) at 8, 16 and 24 weeks post implantation. 
